NCT00064636终止1 期
A Phase I, Open Label, Dose Escalation Study of PS-341 Plus Docetaxel in Treatment-Naive or Previously Treated Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 入组人数
- 46
研究概览
简要总结
The purpose of this study is to evaluate how safe VELCADE (PS-341) is when given with Taxotere (Docetaxel) to patients with non-small cell lung cancer or other solid tumors, and also to see what effects (good and bad) it has on you and your cancer.
详细描述
This is a dose escalation study, which means that the first group of patients who enter the study will receive a low dose of VELCADE and Docetaxel. If the low dose of VELCADE and Docetaxel appears to be safe, then the next group of patients will receive a higher dose of VELCADE and docetaxel.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid TumorsNeoplasms, Advanced SolidNCT02525536Takeda18
终止
1 期
Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMMLMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicNCT01957644Boehringer Ingelheim16
终止
1 期
Phase 1, Dose-Escalation Study of IGN002 in NHL SubjectsNon-Hodgkin LymphomaNCT02519270Spectrum Pharmaceuticals, Inc62
已完成
1 期
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer PatientsBrain CancerHead and Neck CancerCervix CancerCentral Nervous System NeoplasmsNCT00329589Sidney Kimmel Cancer Center at Thomas Jefferson University54
终止
1 期
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell DiseaseSickle Cell DiseaseNCT03132324Incyte Corporation12